The slow approval of coronavirus vaccines by Europe’s Medicines Agencies (EMA) has caused criticism. The fact is: In June 2020 the EU-27 including Austria spoke out against faster emergency approvals, as was the case in Great Britain, for example, but in favor of „conditional approvals“ – this also applies to the next vaccine, which will come from Johnson & Johnson.
